Gene expression profiling of human stenotic aorto-coronary bypass grafts by cDNA array analysis

被引:14
作者
Hilker, M [1 ]
Längin, T
Hake, U
Schmid, FX
Kuroczynski, W
Lehr, HA
Oelert, H
Buerke, M
机构
[1] Univ Mainz, Dept Thorac & Cardiovasc Surg, D-6500 Mainz, Germany
[2] Univ Mainz, Dept Internal Med, D-6500 Mainz, Germany
[3] Univ Regensburg, Dept Thorac & Cardiovasc Surg, D-8400 Regensburg, Germany
[4] Univ Mainz, Dept Pathol, D-6500 Mainz, Germany
关键词
bypass graft disease; cDNA array; c-myc; in situ hybridization;
D O I
10.1016/S1010-7940(03)00017-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Aorto-coronary bypass graft disease with its increasing clinical signification represents an unsolved problem in cardiological and heart surgery practice. Late occlusion of autologous saphenous vein grafts is due to medial and neointimal thickening secondary to migration and proliferation of smooth muscle cells (SMCs) and the subsequent formation of atherosclerotic plaques. This study is aimed at identifying differentially expressed genes in human stenotic bypass grafts to detect unknown pathomechanism and to identify novel targets for prophylactic treatment options. Methods: Stenotic saphenous aorto-coronary bypass grafts (n = 5) were retrieved during re-do aorto-coronary bypass surgery. Ungrafted saphenous vein segments (n = 5) were taken from the same group of patients and served as internal controls. cDNA samples were prepared and hybridized to cDNA arrays. Results: Some of the differentially expressed genes complied with expected gene expression including upregulation of c-jun and CDK10. In addition, previously unidentified gene expression patterns were detected such as upregulation of HSP70, fibronectin1, erbB3 proto-oncogene and c-myc. To confirm the latter finding, upregulation of c-myc in neointimal and medial SMCs of stenotic graft segments was confirmed by in situ hybridization studies and by immunhistochemistry. Conclusion: Gene expression patterns of human stenotic bypass grafts retrieved by re-do operations can be reliably analyzed by cDNA array technology. With this technique, new therapeutic targets in patients could be identified as shown by the findings regarding c-myc. c-myc is a proto-oncogene acting as a transcription factor and blocking c-myc has shown a reduction of neointima formation in animal models. Our study yields a rational for the use of antisense c-myc oligonucleotides to reduce neointima formation and to avoid stenosis in patients. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:620 / 625
页数:6
相关论文
共 26 条
[1]   MORPHOLOGIC CHANGES IN LONG-TERM SAPHENOUS-VEIN BYPASS GRAFTS [J].
ATKINSON, JB ;
FORMAN, MB ;
VAUGHN, WK ;
ROBINOWITZ, M ;
MCALLISTER, HA ;
VIRMANI, R .
CHEST, 1985, 88 (03) :341-348
[2]   DOWN-REGULATION OF THE C-MYC PROTOONCOGENE IN INHIBITION OF VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION - A SIGNAL FOR GROWTH ARREST [J].
BENNETT, MR ;
LITTLEWOOD, TD ;
HANCOCK, DC ;
EVAN, GI ;
NEWBY, AC .
BIOCHEMICAL JOURNAL, 1994, 302 :701-708
[3]   Expression rate of vinculin isoforms in human aortocoronary saphenous vein grafts [J].
Brinck, U ;
Mirzaie, M ;
Korabiowska, M ;
Meyer, T .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1997, 59 (02) :125-132
[4]   THE BIOLOGY OF SAPHENOUS-VEIN GRAFT OCCLUSION - ETIOLOGY AND STRATEGIES FOR PREVENTION [J].
BRYAN, AJ ;
ANGELINI, GD .
CURRENT OPINION IN CARDIOLOGY, 1994, 9 (06) :641-649
[5]   C-MYC ONCOPROTEIN FUNCTION [J].
DANG, CV .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) :103-113
[6]   C-MYC IN VASCULOPROLIFERATIVE DISEASE [J].
EDELMAN, ER ;
SIMONS, M ;
SIROIS, MG ;
ROSENBERG, RD .
CIRCULATION RESEARCH, 1995, 76 (02) :176-182
[7]   Characterization of cellular density and determination of neointimal extracellular matrix constituents in human lower extremity vein graft stenoses [J].
Gentile, AT ;
Mills, JL ;
Westerband, A ;
Gooden, MA ;
Berman, SS ;
Boswell, CA ;
Williams, SK .
CARDIOVASCULAR SURGERY, 1999, 7 (04) :464-469
[8]   An essential role for platelet-derived growth factor in neointima formation in human saphenous vein in vitro [J].
George, SJ ;
Williams, A ;
Newby, AC .
ATHEROSCLEROSIS, 1996, 120 (1-2) :227-240
[9]  
Gibbons GH, 1995, J HEART LUNG TRANSPL, V14, pS149
[10]  
Golja AM, 1995, CELL MOL BIOL RES, V41, P487